Vaniam Group Revenue and Competitors

Chicago, IL USA

Location

N/A

Total Funding

Pharma

Industry

Estimated Revenue & Valuation

  • Vaniam Group's estimated annual revenue is currently $134.1M per year.(i)
  • Vaniam Group's estimated revenue per employee is $201,000

Employee Data

  • Vaniam Group has 667 Employees.(i)
  • Vaniam Group grew their employee count by 57% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$13.1M6530%N/AN/A
#2
$75.6M3767%N/AN/A
#3
$23.9M11913%$35MN/A
#4
$12.7M63-3%N/AN/A
#5
$5.4M27-25%N/AN/A
#6
$6M30-35%N/AN/A
#7
$35.3M391147%$289.7MN/A
#8
$6.6M33-8%N/AN/A
#9
$13.5M67-3%N/AN/A
#10
$186.3M92719%N/AN/A
Add Company

Vaniam Group is a fiercely independent network of 11 healthcare communications agencies that employ over 100 world-class scientific and agency professionals. These professionals include medical strategists, client service experts, industry connectors, and scientific writers? many of whom possess extensive oncology and hematology experience. Since 2007, Vaniam Group has been devoted to helping clients realize the full potential of their oncology and hematology compounds as a people-first and purpose-driven entity. We partner with our clients? commercial, medical, and clinical teams and provide thoughtful guidance throughout the product development life cycle through Strategic Consulting, External Expert Engagement, Scientific Communications, and Insights Gathering. Our 100% virtual operation allows us to be nimble and collaborative, helping clients to create and facilitate the communications that capture interest and drive engagement in oncology drug development, clinical research, and clinical practice. As a certified Evergreen? company, our purpose is to make a long-term difference in the way our clients and our people create, communicate, think, and work within the fields of oncology and hematology.

keywords:N/A

N/A

Total Funding

667

Number of Employees

$134.1M

Revenue (est)

57%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Vaniam Group's People

NameTitleEmail/Phone
1
Account LeadReveal Email/Phone
2
VP, Corporate Communications and Public RelationsReveal Email/Phone
3
Director, Digital SolutionsReveal Email/Phone
4
Executive Director, Medical StrategyReveal Email/Phone
5
Senior Director, Scientific CommunicationsReveal Email/Phone
6
Associate Director, Scientific CommunicationsReveal Email/Phone
7
Director, Clinical Strategy and SolutionsReveal Email/Phone
8
Director, Scientific Commmunications, OncologyReveal Email/Phone
9
Account Executive, Client ServicesReveal Email/Phone
10
Director Project ManagementReveal Email/Phone

Vaniam Group News

2021-07-06 - Vaniam Group LLC announces European and International expansion with addition of new global agency, Vaniam Group Global Ltd

CHICAGO, July 6, 2021 /PRNewswire/ -- Vaniam Group LLC today announced the establishment of Vaniam Group Global Ltd, expanding the company's strategic healthcare communications network footprint into Europe and around the world. Based in the United Kingdom, Vaniam Group Global Ltd is the compa ...

2021-06-18 - Vaniam Group Announces Dr. Quaovi H. Sodji of Stanford University as the Inaugural Recipient of Conquer Cancer-Vaniam Group LLC Young Investigator Award

CHICAGO, June 18, 2021 /PRNewswire/ -- Vaniam Group announced today that the Conquer Cancer-Vaniam Group LLC inaugural Young Investigator Award (YIA) was bestowed upon Quaovi H. Sodji, MD, PhD, of Stanford University for his research in pancreatic cancer. This annual award will provide researc ...

2021-05-13 - Vaniam Group Named to Inc. Magazine's 2021 List of Best Workplaces

We have a bold vision for our future and this recognition signals investing in our team is the smartest choice we could make. CHICAGO (PRWEB) May 13, 2021 Vaniam Group LLC has been named to Inc. magazine’s annual list of the Best Workplaces for 2021. Hitting newsstands May 18 in the May/June 2 ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$213M6718%N/A
#2
$184.8M67210%N/A
#3
$118.1M67510%N/A
#4
$229.2M679-8%N/A
#5
$123.4M6813%$91.5M